Preimplantation Genetic Testing Market to Grow at 10.0% CAGR to 2022 | Top Technologies, Overview, Key Insights and Company Profiles

ReportsnReports always aims at offering their clients an in-depth analysis and the best research material of the various market. This report on the global Preimplantation Genetic Testing market is committed fulfilling the requirements of the clients by giving them thorough insights into the market. An exclusive data offered in this report is collected by research and industry experts team. Preimplantation Genetic Testing market spread across 204 Pages, profiling 10 companies and supported with tables and figures.

Get Free Sample Report of “Preimplantation Genetic Testing Market” at https://www.reportsnreports.com/contacts/requestsample.aspx?name=1128201

Table of Contents
• Introduction
• Research Methodology
• Executive Summary
• Premium Insights
• Preimplantation Genetic Testing Market: Overview
• Industry Insights
• Preimplantation Genetic Diagnosis and Screening Market, By Procedure Type
• Preimplantation Genetic Diagnosis and Screening Market, By Technology
• Preimplantation Genetic Diagnosis and Screening Market, By Product and Service
• Preimplantation Genetic Diagnosis and Screening Market, By Application
• Preimplantation Genetic Diagnosis and Screening Market, By End User
• Preimplantation Genetic Diagnosis and Screening Market, By Region
• Preimplantation Genetic Testing Market: Competitive Landscape
• Company Profiles
• Appendix

The Global Preimplantation Genetic Testing Market is expected to reach US$ 541.8 Million by 2022 from US$ 336.4 Million in 2017, at a CAGR of 10.0%. Growing rate of infertility across the globe, increasing public-private investments in the field of preimplantation genetic testing, rising number of fertility clinics worldwide, technological advancements in the field of genetic analysis, and high risk of chromosomal abnormalities in the fetus with increasing maternal age are some of the key factors driving the growth of this market.

“Next-generation Sequencing is expected to grow at the highest CAGR during 2017 to 2022”
By technology, the preimplantation genetic testing market covers next-generation sequencing (NGS), polymerase chain reaction (PCR), fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and single-nucleotide polymorphism (SNP).

“APAC is projected to witness the highest growth during the forecast period “
North America accounted for the largest share of the market in 2016, Asia-Pacific is expected to register the highest growth rate during the forecast period from 2017 to 2022. This is owing to the focus of key market players in this region, growing number of ART & IVF procedures in the region, continuous decline in average fertility rate, government initiatives for expansion and modernization of healthcare infrastructure across respective countries, and growing medical tourism across APAC countries.

Breakdown of supply-side primary interviews: by company type, designation, and region:
• By Company Type - Tier 1 –50%, Tier 2 –33% and Tier 3 –17%
• By Designation – C level – 17%, Director level – 50%, Others – 33%
• By Region – North America - 34%, Europe – 26%, APAC – 35%, RoW – 5%

The Study Objectives of this report are:

• To forecast the market value of the market segments with respect to four major regions, namely, North America, Europe, Asia-Pacific, and the Rest of the World (RoW)

• To define, describe, and forecast the global preimplantation genetic testing market by technology, product & service, procedure type, application, end user, and region

• To provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and industry-specific challenges)

• To analyze the growth opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders

• To profile the key players and comprehensively analyze their market shares and core competencies

• To track and analyze competitive developments such as product launches, showcases, and approvals; partnerships, agreements, and collaborations; acquisitions; and expansions in the global preimplantation genetic testing market

#Top Key Players in the “Preimplantation Genetic Testing Market” include are Illumina, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Cooper Surgical, Inc. (U.S.), Beijing Genomics Institute (BGI) (China), Abbott Laboratories (U.S.), Natera, Inc. (U.S.), Genea Limited (Australia), Rubicon Genomics, Inc. (U.S.), and Oxford Gene Technology (U.K.).

A Discount can be asked before order a copy of Preimplantation Genetic Testing Market report at https://www.reportsnreports.com/contacts/discount.aspx?name=1128201

#Target Audience/Stakeholders for Preimplantation Genetic Testing Market: Preimplantation Genetic Diagnosis and Screening Product Manufacturing Companies,Preimplantation Genetic Diagnosis and Screening Service Providers,Suppliers/Distributors,Fertility Clinics and Maternity Centers,Clinical Research Organizations (CROs),Academic Institutes and Research Institutes,Medical Reimbursement and Insurance Providers,Independent and Government Regulatory Bodies.

About Us:-
ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.

Corporate Headquarters
Tower B5, office 101,
Magarpatta SEZ,
Hadapsar, Pune-411013, India

This release was published on openPR.